Celgene Careers NewsEmployer Directory Featured Listing, Feeds and Subscriptions

The latest Celgene careers news and job posts. Subscribe for daily updates to your inbox, mobile device and/or smartphone.

  Jobs Feed | Subscribe  

Description Celgene is a global biopharmaceutical company leading the way in medical innovation to help patients live longer, better lives. Our purpose as a company is to discover and develop therapies that will change the course of hum...
Posted: July 19, 2018, 8:12 am
Description Celgene is a global biopharmaceutical company leading the way in medical innovation to help patients live longer, better lives. Our purpose as a company is to discover and develop therapies that will change the course of hum...
Posted: July 19, 2018, 8:12 am
Description Celgene is a global biopharmaceutical company leading the way in medical innovation to help patients live longer, better lives. Our purpose as a company is to discover and develop therapies that will change the course of hum...
Posted: July 19, 2018, 8:11 am
Description Celgene is a global biopharmaceutical company leading the way in medical innovation to help patients live longer, better lives. Our purpose as a company is to discover and develop therapies that will change the course of hum...
Posted: July 19, 2018, 8:11 am
Description Celgene is a global biopharmaceutical company leading the way in medical innovation to help patients live longer, better lives. Our purpose as a company is to discover and develop therapies that will change the course of hum...
Posted: July 18, 2018, 8:08 am

Viewing page 1 of 100|Next Page

  Newsfeed | Subscribe  

Celgene (NASDAQ:CELG) continues to struggle. A series of self-inflicted wounds and a looming patent expiration plague the Summit, New Jersey-based firm. As a result, CELG stock has lost more than 40% ...
Posted: July 18, 2018, 7:23 pm
CNBC's Jim Cramer was somewhat surprised to see the biotechnology sector bounce back in 2018 after months of weakness. "But you know what? After spending a long time in the doghouse, biotech as a whol...
Posted: July 17, 2018, 3:48 pm
Sen. Bob Menendez has yet to run a single television ad in his reelection campaign despite his Republican opponent, Bob Hugin, having already spent millions in his effort to defeat the New Jersey Demo...
Posted: July 13, 2018, 12:06 pm
Shares of blue-chip biotech Celgene Corporation (NASDAQ:CELG) fell by a staggering 23.9% through the first six months of this year, according to data from S&P Global Market Intelligence. The biotech's ...
Posted: July 13, 2018, 4:31 am
On Wednesday, an appeals board of the U.S. Patent and Trademark Office upheld a patent protecting Novartis' Gilenya until December 2027. This extends Gilenya's exclusivity well past a prior August 201...
Posted: July 12, 2018, 10:21 am

Viewing page 1 of 3|Next Page